(+)-schisandrin B multiple interactions ISO RGD:68362 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRAT mRNA] CTD PMID:31150632 1,1-dichloroethene decreases expression EXP 6480464 vinylidene chloride results in decreased expression of LRAT mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of LRAT mRNA CTD PMID:22206623 1-naphthyl isothiocyanate decreases expression ISO RGD:68362 6480464 1-Naphthylisothiocyanate results in decreased expression of LRAT mRNA CTD PMID:25380136 17alpha-ethynylestradiol increases expression ISO RGD:68362 6480464 Ethinyl Estradiol results in increased expression of LRAT mRNA CTD PMID:17557909 17beta-estradiol multiple interactions ISO RGD:68515 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of LRAT mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases activity ISO RGD:68362 6480464 Tetrachlorodibenzodioxin results in increased activity of LRAT protein CTD PMID:11097864 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:68362 6480464 Tetrachlorodibenzodioxin affects the expression of LRAT mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:68362 6480464 Tetrachlorodibenzodioxin results in increased expression of LRAT mRNA CTD PMID:12606150 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:68362 6480464 [Tetrachlorodibenzodioxin results in increased activity of LRAT protein] which results in increased chemical synthesis of Tretinoin CTD PMID:11097864 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of LRAT mRNA more ... CTD PMID:16292751 , PMID:25975270 2-bromohexadecanoic acid increases expression ISO RGD:68362 6480464 2-bromopalmitate results in increased expression of LRAT mRNA CTD PMID:12576510 4,4'-diaminodiphenylmethane decreases expression ISO RGD:68362 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of LRAT mRNA CTD PMID:25380136 , PMID:30723492 4,4'-sulfonyldiphenol increases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of LRAT mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of LRAT mRNA CTD PMID:28973697 aflatoxin B1 increases methylation ISO RGD:68515 6480464 Aflatoxin B1 results in increased methylation of LRAT gene CTD PMID:28458013 all-trans-retinoic acid increases expression ISO RGD:68515 6480464 Tretinoin results in increased expression of LRAT protein CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:68362 6480464 Tretinoin results in increased expression of LRAT mRNA CTD PMID:21138835 all-trans-retinoic acid decreases expression ISO RGD:68515 6480464 Tretinoin results in decreased expression of LRAT mRNA CTD PMID:21934132 all-trans-retinoic acid multiple interactions ISO RGD:68362 6480464 [Tetrachlorodibenzodioxin results in increased activity of LRAT protein] which results in increased chemical synthesis of Tretinoin CTD PMID:11097864 all-trans-retinol multiple interactions ISO RGD:68515 6480464 [STRA6 protein co-treated with LRAT protein] results in increased uptake of Vitamin A CTD PMID:18316031 all-trans-retinol decreases expression EXP 6480464 Vitamin A results in decreased expression of LRAT mRNA CTD PMID:30944279 all-trans-retinol affects expression ISO RGD:68362 6480464 Vitamin A affects the expression of LRAT mRNA CTD PMID:12576510 all-trans-retinol increases expression EXP 6480464 Vitamin A results in increased expression of LRAT mRNA CTD PMID:16292751 all-trans-retinol multiple interactions EXP 6480464 [Vitamin A co-treated with Tetrachlorodibenzodioxin] results in increased expression of LRAT mRNA, Tetrachlorodibenzodioxin inhibits the reaction [Vitamin A results in increased expression of LRAT mRNA] CTD PMID:16292751 ammonium chloride affects expression ISO RGD:68362 6480464 Ammonium Chloride affects the expression of LRAT mRNA CTD PMID:16483693 arachidonic acid increases expression ISO RGD:68362 6480464 Arachidonic Acid results in increased expression of LRAT mRNA CTD PMID:12576510 aristolochic acid A decreases expression ISO RGD:68515 6480464 aristolochic acid I results in decreased expression of LRAT mRNA CTD PMID:33212167 arotinoid acid increases expression ISO RGD:68362 6480464 4-(2-(5 more ... CTD PMID:12576510 benzo[a]pyrene increases expression ISO RGD:68515 6480464 Benzo(a)pyrene results in increased expression of LRAT mRNA CTD PMID:22316170 benzo[a]pyrene increases methylation ISO RGD:68515 6480464 Benzo(a)pyrene results in increased methylation of LRAT promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of LRAT mRNA CTD PMID:22610609 beta-naphthoflavone multiple interactions ISO RGD:68362 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LRAT mRNA CTD PMID:18164116 bisphenol A multiple interactions ISO RGD:68362 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of LRAT mRNA CTD PMID:26496021 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LRAT mRNA CTD PMID:35598803 bisphenol A decreases expression ISO RGD:68362 6480464 bisphenol A results in decreased expression of LRAT mRNA CTD PMID:34947998 bisphenol A multiple interactions EXP 6480464 [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in decreased expression of CYP2C39 mRNA more ... CTD PMID:28123100 bisphenol A affects response to substance EXP 6480464 LRAT gene mutant form affects the susceptibility to bisphenol A CTD PMID:28123100 bisphenol A affects expression ISO RGD:68362 6480464 bisphenol A affects the expression of LRAT mRNA CTD PMID:25181051 buspirone decreases expression ISO RGD:68362 6480464 Buspirone results in decreased expression of LRAT mRNA CTD PMID:24136188 captan decreases expression EXP 6480464 Captan results in decreased expression of LRAT mRNA CTD PMID:31558096 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon analog affects the expression of LRAT mRNA CTD PMID:25554681 carbon nanotube decreases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:68515 6480464 CGP 52608 promotes the reaction [RORA protein binds to LRAT gene] CTD PMID:28238834 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of LRAT mRNA CTD PMID:23125180 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of LRAT mRNA CTD PMID:32715474 clorgyline increases expression ISO RGD:68515 6480464 Clorgyline results in increased expression of LRAT mRNA CTD PMID:19691856 cyproconazole decreases expression EXP 6480464 cyproconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 dibenz[a,h]anthracene increases expression EXP 6480464 1 more ... CTD PMID:26377693 diethylstilbestrol increases expression ISO RGD:68362 6480464 Diethylstilbestrol results in increased expression of LRAT mRNA CTD PMID:21658437 dioxygen multiple interactions EXP 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LRAT mRNA CTD PMID:30529165 dopamine increases expression ISO RGD:68362 6480464 Dopamine results in increased expression of LRAT mRNA CTD PMID:21983523 dorsomorphin multiple interactions ISO RGD:68515 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRAT mRNA CTD PMID:27188386 entinostat increases expression ISO RGD:68515 6480464 entinostat results in increased expression of LRAT mRNA CTD PMID:27188386 epoxiconazole decreases expression EXP 6480464 epoxiconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 ethanol multiple interactions ISO RGD:68515 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LRAT mRNA CTD PMID:23378141 ethanol increases expression ISO RGD:68515 6480464 Ethanol results in increased expression of LRAT mRNA CTD PMID:23378141 , PMID:28986285 fenoldopam increases expression ISO RGD:68362 6480464 Fenoldopam results in increased expression of LRAT mRNA CTD PMID:21983523 fenthion increases expression EXP 6480464 Fenthion results in increased expression of LRAT mRNA CTD PMID:34813904 folic acid multiple interactions ISO RGD:68515 6480464 [Ethanol co-treated with Folic Acid] results in increased expression of LRAT mRNA CTD PMID:23378141 folpet decreases expression EXP 6480464 folpet results in decreased expression of LRAT mRNA CTD PMID:31558096 furan increases expression ISO RGD:68362 6480464 furan results in increased expression of LRAT mRNA CTD PMID:25539665 more ... furan decreases methylation ISO RGD:68362 6480464 furan results in decreased methylation of LRAT gene CTD PMID:27387713 glafenine decreases expression ISO RGD:68362 6480464 Glafenine results in decreased expression of LRAT mRNA CTD PMID:24136188 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of LRAT mRNA CTD PMID:20003209 isotretinoin increases expression ISO RGD:68515 6480464 Isotretinoin results in increased expression of LRAT protein CTD PMID:15982314 linoleic acid increases expression ISO RGD:68362 6480464 Linoleic Acid results in increased expression of LRAT mRNA CTD PMID:12576510 manganese atom increases expression ISO RGD:68362 6480464 Manganese results in increased expression of LRAT mRNA CTD PMID:26745496 manganese(0) increases expression ISO RGD:68362 6480464 Manganese results in increased expression of LRAT mRNA CTD PMID:26745496 manganese(II) chloride increases expression ISO RGD:68362 6480464 manganese chloride results in increased expression of LRAT mRNA CTD PMID:26745496 methidathion increases expression EXP 6480464 methidathion results in increased expression of LRAT mRNA CTD PMID:34813904 Muraglitazar increases expression ISO RGD:68362 6480464 muraglitazar results in increased expression of LRAT mRNA CTD PMID:21515302 N-nitrosodiethylamine increases response to substance EXP 6480464 LRAT protein results in increased susceptibility to Diethylnitrosamine CTD PMID:21278145 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of LRAT mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LRAT mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:68362 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of LRAT mRNA CTD PMID:18164116 N-nitrosodimethylamine decreases expression ISO RGD:68362 6480464 Dimethylnitrosamine results in decreased expression of LRAT mRNA CTD PMID:25380136 nefazodone decreases expression ISO RGD:68362 6480464 nefazodone results in decreased expression of LRAT mRNA CTD PMID:24136188 nickel sulfate decreases expression EXP 6480464 nickel sulfate results in decreased expression of LRAT mRNA CTD PMID:16100012 nimesulide decreases expression ISO RGD:68362 6480464 nimesulide results in decreased expression of LRAT mRNA CTD PMID:24136188 nitrofen increases expression ISO RGD:68362 6480464 nitrofen results in increased expression of LRAT mRNA, nitrofen results in increased expression of LRAT protein CTD PMID:24972641 , PMID:33484710 nitrofen decreases expression ISO RGD:68362 6480464 nitrofen results in decreased expression of LRAT mRNA CTD PMID:17203325 , PMID:26720608 ozone decreases expression ISO RGD:68362 6480464 Ozone results in decreased expression of LRAT mRNA CTD PMID:35737395 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of LRAT mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:68515 6480464 perfluorooctane sulfonic acid results in decreased expression of LRAT mRNA CTD PMID:27153767 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LRAT mRNA CTD PMID:24535843 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of LRAT mRNA CTD PMID:23091169 phenylmercury acetate multiple interactions ISO RGD:68515 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRAT mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of LRAT mRNA CTD PMID:18445702 potassium dichromate affects expression EXP 6480464 Potassium Dichromate affects the expression of LRAT mRNA CTD PMID:23608068 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of LRAT mRNA CTD PMID:22334560 resveratrol multiple interactions ISO RGD:68515 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of LRAT mRNA CTD PMID:23557933 retinyl acetate multiple interactions EXP 6480464 [LRAT gene mutant form affects the susceptibility to [bisphenol A co-treated with retinol acetate]] which results in decreased expression of CYP2C39 mRNA more ... CTD PMID:24614237 , PMID:28123100 rotenone decreases expression ISO RGD:68362 6480464 Rotenone results in decreased expression of LRAT mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:68515 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of LRAT mRNA CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide results in decreased expression of LRAT mRNA CTD PMID:23221170 , PMID:29341224 silicon dioxide decreases expression ISO RGD:68515 6480464 Silicon Dioxide results in decreased expression of LRAT mRNA CTD PMID:25351596 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of LRAT mRNA CTD PMID:32068019 sodium dichromate increases expression ISO RGD:68362 6480464 sodium bichromate results in increased expression of LRAT mRNA CTD PMID:22561333 sunitinib increases expression ISO RGD:68515 6480464 Sunitinib results in increased expression of LRAT mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:68362 6480464 [bisphenol A co-treated with Testosterone] results in decreased expression of LRAT mRNA CTD PMID:26496021 tetrachloroethene increases expression EXP 6480464 Tetrachloroethylene results in increased expression of LRAT mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LRAT mRNA CTD PMID:27339419 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of LRAT mRNA CTD PMID:31919559 tetrachloromethane decreases expression ISO RGD:68362 6480464 Carbon Tetrachloride results in decreased expression of LRAT mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:68362 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LRAT mRNA] CTD PMID:31150632 thioacetamide multiple interactions EXP 6480464 retinol acetate inhibits the reaction [LRAT gene mutant form results in decreased susceptibility to Thioacetamide] CTD PMID:24614237 thioacetamide decreases response to substance EXP 6480464 LRAT gene mutant form results in decreased susceptibility to Thioacetamide CTD PMID:24614237 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of LRAT mRNA CTD PMID:23409001 more ... titanium dioxide decreases expression ISO RGD:68362 6480464 titanium dioxide results in decreased expression of LRAT mRNA CTD PMID:30012374 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of LRAT mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LRAT mRNA CTD PMID:28973375 triclosan decreases expression ISO RGD:68515 6480464 Triclosan results in decreased expression of LRAT mRNA CTD PMID:30510588 triphenyl phosphate decreases expression ISO RGD:68362 6480464 triphenyl phosphate results in decreased expression of LRAT mRNA CTD PMID:30589522 troglitazone increases expression ISO RGD:68362 6480464 troglitazone results in increased expression of LRAT mRNA CTD PMID:21515302 valdecoxib decreases expression ISO RGD:68362 6480464 valdecoxib results in decreased expression of LRAT mRNA CTD PMID:24136188 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of LRAT mRNA CTD PMID:17963808 valproic acid increases expression ISO RGD:68515 6480464 Valproic Acid results in increased expression of LRAT mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:68515 6480464 Valproic Acid affects the expression of LRAT mRNA CTD PMID:25979313 vinclozolin increases expression ISO RGD:68362 6480464 vinclozolin results in increased expression of LRAT mRNA CTD PMID:23034163 zaragozic acid A decreases expression ISO RGD:68362 6480464 squalestatin 1 results in decreased expression of LRAT mRNA CTD PMID:27225895 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of LRAT mRNA CTD PMID:27225895